Bionomics director Aaron Weaver resigns from board effective Oct 9, 2024

Neuphoria Therapeutics Inc.

Aaron Weaver resigned from Bionomics' Board of Directors on October 9, 2024.
Resignation does not involve any disagreement on operations, policies, or practices.
Weaver served on the board for four years; company thanked him and wished him well.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Aaron Weaver

Director

NEUP · Neuphoria Therapeutics Inc.

Effective: 2024-10-09
Filed: October 10, 2024, 7:59 PM ET

On October 9, 2024, Mr. Aaron Weaver, a member of the Board of Directors of Bionomics Limited (the “Company”), provided the Company’s board with notice that he was resigning from the Board of Directors, effective October 9, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Aaron Weaver resigned as Director at Neuphoria Therapeutics Inc..

Action: resigned
Role: Director

Exact text from the filing

On October 9, 2024, Mr. Aaron Weaver, a member of the Board of Directors of Bionomics Limited (the “Company”), provided the Company’s board with notice that he was resigning from the Board of Directors, effective October 9, 2024.

View on SEC.gov

Neuphoria Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-086918

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.